Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Atlas Arteria's Total Liabilities for the quarter that ended in Dec. 2025 was $1,231.6 Mil. Atlas Arteria's Total Assets for the quarter that ended in Dec. 2025 was $5,086.9 Mil.
Therefore, Atlas Arteria's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2025 was 0.24.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Atlas Arteria Liabilities-to-Assets Related Terms
Atlas Arteria Liabilities-to-Assets Historical Data
* Premium members only.
The historical data trend for Atlas Arteria's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Infrastructure Operations subindustry, Atlas Arteria's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Atlas Arteria Liabilities-to-Assets vs Construction Industry
For the Construction industry and Industrials sector, Atlas Arteria's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Atlas Arteria's Liabilities-to-Assets falls into.
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Atlas Arteria's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Atlas Arteria (MAQAF) has a Liabilities-to-Assets of 0.24 as of Dec. 2025. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Atlas Arteria and its competitors.
Is Atlas Arteria's Liabilities-to-Assets too high?
Atlas Arteria's current Liabilities-to-Assets is 0.24. Overall, Atlas Arteria has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's Liabilities-to-Assets compare to competitors?
Atlas Arteria's Liabilities-to-Assets of 0.24 can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Construction company?
A good Liabilities-to-Assets depends on the Construction industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Atlas Arteria and its competitors. Atlas Arteria's current Liabilities-to-Assets is 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (MAQAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.06, compared to a current price of $3.30 — trading 18.7% below its estimated fair value. The current Liabilities-to-Assets is 0.24. Atlas Arteria's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Atlas Arteria (MAQAF), the current Liabilities-to-Assets is 0.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Atlas Arteria (MAQAF) Overvalued in 2026?
Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued.
The current stock price of $3.30 is trading 18.7% below its estimated GF Value™ of $4.06.
GuruFocus considers Atlas Arteria to be Modestly Undervalued.
Key valuation signals for MAQAF:
Liabilities-to-Assets: 0.24
GF Value™: $4.06 vs. price of $3.30 (18.7% below fair value)
No single metric tells the full story. See the MAQAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
76GF Score
Get the complete analysis for MAQAF
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAQAF has been successfully added to your 
